Margins |
m
(0)
| max
l
(m*(l)) | med
l
(m*(l)) | min
l
(m*(l)) |
|---|
Leukemia | 0.20 | 0.05 | -0.01 | -2.41 |
Breast cancer | 1.29 | 0.23 | 0.04 | -0.82 |
Prostate | 0.05 | 0.02 | -0.04 | -0.90 |
Colon | 0.08 | 0.05 | -0.12 | -1.39 |
SRBCT | 1.00 | 0.11 | -0.06 | -1.16 |
Lymphoma | 1.65 | 0.14 | 0.01 | -1.16 |
Brain | 1.03 | 0.32 | 0.09 | -0.29 |
NCI | 2.52 | 0.44 | 0.12 | -0.91 |
- Margins m(0) from the original datasets, as well as maximal, median and minimal margins m*(l) from 1,000 permuted replicates, for leukemia data (AML/ALL distinction), breast cancer data (ER-positive/ER-negative distinction), prostate data (tumor/normal distinction), colon data (tumor/normal distinction), SRBCT data (distinction of the Ewing family of tumors versus three other tumor types), lymphoma data (distinction of DLBCL versus FL and CLL), brain tumor data (separation of atypical teratoid/rhabdoid tumors (AT/RTs) against 4 other tumor types) and NCI data (distinction of leukemia against seven other cancers).
